Dec 21, 2012

Legionella Testing Technology Expands to International Markets

Conforlab of Brazil signs on as Phigenics LLC first licensing partner

Phigenics LLC has launched a licensing practice for its patented Legionella testing technology. Conforlab Engenharia Ambiental LTDA of Sao Paulo signed on as the first licensee in December 2012.

Through this licensing arrangement, Conforlab will provide the patented Phigenics Validation Test (PVT) for validation of biological hazard control in potable and utility water systems throughout all major regions of South America. Conforlab analysts received onsite training at the Phigenics laboratory in Naperville, Ill., to receive the required certification. Conforlab is now in position to receive the testing materials from Phigenics and to conduct the PVT test from their own laboratory in Sao Paulo. Conforlab will also be utilizing Phigenics software to maintain records and report results to its clients.

"We needed a more accurate, faster Legionella testing technology to meet growing customer needs in Brazil for ensuring water safety," said Marcos Bensoussan, president of SETRI, Consultoria em Sustentabilidade, Brazil. "In our analysis, Phigenics offers the best available solution that is practical to apply in the field and an improvement in testing accuracy and speed as compared to conventional methods."

According to the U.S. Department of Labor's Occupational Safety and Health Administration, there are 4,000 deaths from legionellosis each year in the U.S. According to the Centers for Disease Control and Prevention, each year, between 8,000 and 18,000 people are afflicted with Legionnaires' disease in the U.S., and death can occur in up to 30% of cases. The number of annual cases in Europe is estimated by the World Health Organization at around 10,000, and the total global number of cases is many multiples of that.

PVT incorporates a patented TimeZero test method that inoculates Legionella bacteria immediately on site using a dip slide field sampler format.